BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Mesh Bio and MultiOmic Health partner to advance precision medicines and diagnostics for chronic metabolic disease in Asia with AI

Mesh will collaborate with its network of healthcare provider customers to recruit patients for the study. MultiOmic will generate genomic, proteomic, meta...

June 30, 2022 | News

Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

R520A is an mRNA COVID-19 vaccine specifically targeting the Omicron variant developed by Wuhan Recogen Biotechnology Co., Ltd., a subsidiary of the Compan...

June 28, 2022 | News

COVID-19 causes increased risk of developing neurodegenerative disorders

Covid-19-positive outpatients have a higher risk of neurodegenerative disorders compared to people who tested negative for the virus, a new study presented...

June 27, 2022 | News

Keystone Lab Announces Addition of Delta-8 THC & CBD Metabolites Testing to its Testing Menu

Delta-8 THC is a commonly occurring cannabinoid found in most cannabis plants and formed by degradation upon exposure to heat or light resulting in a bond ...

June 21, 2022 | News

BGI Genomics supports post-pandemic recovery in Hong Kong

As of May 31, 2022, BGI Genomics (300676.SZ) conducted approximately 446,000 and 5.7 million COVID-19 tests at the airport and Com...

June 15, 2022 | News

FDA Recommends EUA of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the...

June 09, 2022 | News

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions announce a new SARS-CoV-2 antibody cocktail

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2 Prot...

June 08, 2022 | News

Taiwan's AcadeMab develops groundbreaking therapy for COVID-19 Omicron variant with potent neutralizing efficacy

AcadeMab's treatment specifically targets the SARS-CoV-2 Omicron variant – currently the most common strain of COVID infections around the world. "I...

May 30, 2022 | News

Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic

Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for stayi...

May 26, 2022 | News

LumiraDx Receives WHO Emergency Use Listing for SARS-CoV-2 Ag Test

The LumiraDx antigen test is a microfluidic immunofluorescence assay that delivers results for the direct and qualitative detection of nucleocapsid protein...

May 23, 2022 | News

CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

In addition to shortening the vaccination cycle by leveraging the advantages of its single-dose regimen, Convidecia™ can be stably transported and st...

May 20, 2022 | News

ASEAN to build its own CDC to mitigate another pandemic risk

Indonesian Health Minister Budi Gunadi Sadikin said that Southeast Asia's regional bloc agreed to solidify the three main pillars of pa...

May 18, 2022 | News

A novel universal antiviral drug introduced in Korea

The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...

May 13, 2022 | News

Clinical Trial Approval For ReCOV In The PRC And The Overseas Clinical Trial Progress Of ReCOV

As disclosed in the prospectus of the Company dated March 21, 2022, the Group had initiated subject enrollment for the phase II/III clinical trial for...

May 06, 2022 | News

Stay Connected